Pluri Inc. Operating Leases, Future Minimum Payments Receivable, in Four Years
Pluri Inc. (PLUR) had Operating Leases, Future Minimum Payments Receivable, in Four Years of $528.00 thousand as of 2019-12-31, per its 10-Q filed 2020-02-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFourYears · last filed 2020-02-06
- 2019-12-31: Operating Leases, Future Minimum Payments Receivable, in Four Years $528.00K.
- 2019-09-30: Operating Leases, Future Minimum Payments Receivable, in Four Years $524.00K.
| Period end | Operating Leases, Future Minimum Payments Receivable, in Four Years |
|---|---|
| 2019-12-31 | $528.00K 10-Q · filed 2020-02-06 |
| 2019-09-30 | $524.00K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |